期刊文献+

胺碘酮治疗心衰合并心律失常临床效果探析 被引量:1

Investigation of the Clinical Effect of Amiodarone in the Treatment of Heart Failure Complicated by Arrhythmia
下载PDF
导出
摘要 目的研究胺碘酮治疗心衰合并有心律失常的临床效果,以供临床参考使用。方法收集2012年12月—2014年9月来该院治疗的174例患者,随机将其等分为两组,对照组与实验组。对照组给予常规治疗,实验组在常规治疗措施基础上再予以静脉注射胺碘酮治疗。1个疗程后对比两组患者的心率、心功能情况以及心律失常改善情况,记录临床疗效。结果实验组患者死亡者7例(8.15%),存活率为91.95%;对照组患者死亡者16例(18.39%),存活率为81.61%;实验组心功能改善程度明显的优于对照组,差异有统计学意义(P<0.05)。结论在心衰合并有心律失常的治疗过程中,常规治疗加上胺碘酮治疗可以有效地改善患者的心功能以及心律失常的症状,临床疗效较好。 Objective To investigate the clinical effect of amiodarone in the treatment of heart failure complicated by arrhythmia so as to provide a reference for the clinical practice.Methods 174 cases with heart failure complicated by arrhythmia treated in our hospital from December 2012 to September 2014 were selected and randomly divided into two groups,the control group and the experimental group.Both groups were given the conventional treatment,in addition,the experimental group were given intravenous injection of amiodarone.After 1 course of treatment,the improvement in heart rate,heart function and arrhythmia was compared between the two groups,and the clinical efficacy of both groups was recorded.Results In the experimental group,7 patients(8.15%) died,the survival rate was 91.95%;in the control group,16 cases(18.39%) died,the survival rate was 81.61%;which showed that the improvement in heart function was much better in the experimental group than in the control group,P〈0.05.Conclusion For the treatment of heart failure complicated by arrhythmia,conventional treatment combined with amiodarone can effectively improve the heart function and arrhythmia with good clinical efficacy.
机构地区 益阳市中心医院
出处 《中外医疗》 2015年第17期4-5,8,共3页 China & Foreign Medical Treatment
关键词 胺碘酮 心衰 心律失常 Amiodarone Heart failure Arrhythmia
  • 相关文献

参考文献12

二级参考文献54

  • 1郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 2方圻,王思让.心律失常的临床对策[J].中华心血管病杂志,1993,21(1):5-14. 被引量:39
  • 3Khan IA. Pharmacological cardioversion of recent onset atrial Fbrillation[J]. Eur Heart J ,2004 ,25 : 1 274.
  • 4Hammitl SC. Cardiac arrhythmias[J].JACC, 2004,44 (suppl2) : 16A.
  • 5Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
  • 6Hammill SC.Cardiac arrhythmias[J].JACC,2004,44(suppl 2):16A
  • 7Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
  • 8The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
  • 9Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852
  • 10Khan IA.Pharmacological cardioversion of recent onset atrial fibrillation[J]. Eur Heart J ,2004,25:1 274

共引文献1228

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部